国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING UV SPECTROPHOTOMETRIC SIMULTANEOUS EQUATION METHOD FOR DETERMINATION OF EZETIMIBE AND GLIMEPIRIDE IN BULK DRUGS AND MARKETED FORMULATION

Hanifa Begum, Sh. Rizwan, Khaled Bin Sayeed, Asiya Fatima

Ezetimibe and Glimepiride used as Anti - hypercholesterolemia drugs. A simple , specific, accurate and precise stability indicating UV spectroscopy method has been developed and validated for simultaneous determination of Ezetimibe and Glimepiride in bulk drugs and marketed formulation (tablets). The developed method involves solving of simultaneous equations (Vierodt's method) using methanol as solvent where absorbance maxima λ max for GLIM and EZET was found to be at 226nm and 233nm respectively. Both the drugs obeyed Beer's law in the concentration range of 10- 30 μg/ ml & 1 – 3 μg/ ml. The method was validated as per ICH guidelines values of correlation coefficients (r2) 0.99 indicated good linearity of Calibration curve for both the drugs. The recovery of GLIM and EZET from the standard mixture solution was 99.65% and 100.3% respectively. The developed method was found to be accurate, reliable robust showing LOD 2.64 μg/ml (GLIM) and 26.4 μg/ml (EZET) and LOQ 8 μg/ml (GLIM) and 80 μg/ml(EZET) . Forced degradation was also performed the obtained spectra doesn’t show any degradation products under any stress conditions applied. Hence the method developed is stability indicating and can be used for estimation of EZET and GLIM in routine lab analysis.